Article info
Immunotherapy biomarkers
Original research
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
- Correspondence to Professor Chang Chen; chenthoracic{at}163.com; Professor Jie Tian; jie.tian{at}ia.ac.cn; Dr Tao Jiang; tonyjiangdr{at}163.com; Professor Zhipei Huang; zphuang{at}ucas.ac.cn
Citation
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
Publication history
- Accepted May 29, 2020
- First published July 6, 2020.
Online issue publication
July 06, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.